+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 50Years
All Genders
Healthy Volunteers
ID07535099

Phase I Study to Assess Safety and Effects of Single and Multiple Doses of ICP-538 Tablets in Healthy Adults Aged 18 to 50

Led by Beijing InnoCare Pharma Tech Co., Ltd. · Updated on 2026-06-18

104

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a Phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of ICP-538 in healthy adult participants. The study aims to understand how the drug behaves in the body and monitor any adverse effects in a controlled setting. This trial is sponsored by Beijing InnoCare Pharma Tech Co., Ltd. and focuses on healthy individuals aged 18 to 50 years. Participants will receive either single ascending doses or multiple ascending doses of ICP-538 tablets or matching placebo tablets. The study uses a parallel design with randomized allocation and quadruple masking to ensure unbiased results. Dosing and monitoring will occur over a period that can last up to 7 weeks, during which the drugs effects and behavior in the body will be closely observed. During the study, participants will undergo regular assessments including vital signs, physical examinations, laboratory tests, ECGs, chest X-rays, and abdominal ultrasounds to track safety and drug effects. Researchers will measure treatment-emergent adverse events, abnormalities in laboratory tests, and vital signs throughout the study period. Participant involvement includes signing informed consent, adhering to study protocols, and attending scheduled visits for evaluations and monitoring until study completion.

CONDITIONS

Brief Title

Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ICP-538 in Healthy Subjects

Research Team

Q

Quankun Zhuang

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here